ACE and diabetic kidney disease: In these patients, treatment with statins, angiotension-converting enzyme (ACE) inhibitors, or angiotensin-receptor blockers can delay the progression of kidney disease and reduce cardiovascular morbidity, whereas glucose-lowering therapy can prevent and delay the progression of DKD (13).